MARSHALL WACE, LLP: REPX position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of MARSHALL WACE, LLP on REPX, newest first. How the timeline and the estimate are built.
MARSHALL WACE, LLP held 0 REPX shares at 2026-06-30 per its 13F-HR filed 2026-08-13.
the latest 13F is the newest step
- period ended2026-06-3013F 0 sharesChange vs previous 13F -306,556 shares
13F-HR 0001318757-26-000010 filed by MARSHALL WACE, LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
Exited: the 13F for this period no longer lists the position.
- period ended2026-03-3113F 306,556 sharesChange vs previous 13F +306,556 shares
0.01% of the 13F portfolio, value $11,173,967.
13F-HR 0001318757-26-000005 filed by MARSHALL WACE, LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 0 sharesChange vs previous 13F -31,582 shares
13F-HR 0001318757-25-000023 filed by MARSHALL WACE, LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
Exited: the 13F for this period no longer lists the position.
- period ended2024-12-3113F 31,582 sharesChange vs previous 13F -19,094 shares
<0.01% of the 13F portfolio, value $1,008,098.
13F-HR 0002048047-25-000005 filed by MARSHALL WACE, LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-09-3013F 50,676 sharesChange vs previous 13F not available
<0.01% of the 13F portfolio, value $1,342,407.
13F-HR 0001318757-24-000018 filed by MARSHALL WACE, LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).